Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Share-based Compensation: 2009-2024

Historic Share-based Compensation for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $1.3 million.

  • Rockwell Medical's Share-based Compensation rose 65.73% to $532,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 54.34%. This contributed to the annual value of $1.3 million for FY2024, which is 38.63% up from last year.
  • Per Rockwell Medical's latest filing, its Share-based Compensation stood at $1.3 million for FY2024, which was up 38.63% from $932,000 recorded in FY2023.
  • Over the past 5 years, Rockwell Medical's Share-based Compensation peaked at $1.3 million during FY2024, and registered a low of $315,000 during FY2022.
  • Its 3-year average for Share-based Compensation is $846,333, with a median of $932,000 in 2023.
  • As far as peak fluctuations go, Rockwell Medical's Share-based Compensation tumbled by 90.41% in 2020, and later soared by 195.87% in 2023.
  • Yearly analysis of 5 years shows Rockwell Medical's Share-based Compensation stood at $475,000 in 2020, then spiked by 98.53% to $943,000 in 2021, then slumped by 66.60% to $315,000 in 2022, then surged by 195.87% to $932,000 in 2023, then surged by 38.63% to $1.3 million in 2024.